-
Sunday, 01/26/2020
Patricia Oscanoa selected by the research contracts “Emili Letang-Josep Font” in Prof. Antoni Torres research group
This research contracts selects the best scientific projects in medical residents during their last year in Hospital Clinic de Barcelona.
The clinical research contracts “Emili Letang-Josep Font” has been resolved. Dra. Patricia Oscanoa: From Peru, she lives in Barcelona. She joined the Bronchiectasis Research Group directed by Prof. Antoni Torres 3 years ago.This program offers the opportunity to develop a research project with a 2 year temporary contract and professional category of specialist. During this time the researcher must focus intensively on the activity related to the project, which will also constitute the material of her doctoral thesis.The objective of the contracts is to capture young medical researchers, a profile that is especially necessary in the environment of Hospital Clinic de Barcelona.The project aimed at studying the prognostic value of Biofire Film Array pneumonia panel in bronchiectasis exacerbations is related with a FIS project 2018 directed by Prof. Antoni Torres Martí, research group leader, and Dr. Laia Fernandez-Barat, coordinator of the research microbiology laboratory. -
Saturday, 01/25/2020
Prof. Antoni Torres Martí group leader of IAMR research group on the 7 out of 20 best Spanish researchers in Medicine
An interesting article published in:
https://www.lainformacion.com/asuntos-sociales/massague-a-la-cabeza-del-ranking-de-los-mejores-cientificos-espanoles/6536647/https://www.lainformacion.com/asuntos-sociales/massague-a-la-cabeza-del-ranking-de-los-mejores-cientificos-espanoles/6536647/https://www.lainformacion.com/asuntos-sociales/massague-a-la-cabeza-del-ranking-de-los-mejores-cientificos-espanoles/6536647/
Highlights Dr. Antonio Torres, the IAMR group leader, on the 7th position of the 20 most important Spanish researchers in Medicine.
-
Friday, 12/20/2019
IAMR achieved funding for one project at the health national call 2019 (FIS)
The success warrants funding for the next three years in the laboratory and in the Community-Acquired Pneumonia research line
Dr. Catia Cillóniz and Dr. Nestor Soler co-leaded the project entitled “Phenotypes related to short and long-term outcomes in community-acquired pneumonia ”. This project achieved 183.000 euros.
-
Monday, 11/25/2019
Kasra kiarostami joins the IAMR group for his UB Master in Translational Medicine
As a veterinarian, he is deeply involved in the study of ETT-biofilm after Telavancin treatment in the pig animal model
Kasra kiarostami holds a Degree in veterinary of parasitology by the University of Azad since 2013 and he is currently performing a research stay associated with the Master in Translational Medicine-MSc at the Cellex laboratory, School of Medicine, University of Barcelona. He joined the IAMR group in November 2019 in order to do his Master Thesis, which he will defend in June 2020.
He works on a randomized clinical trial focused on the study focused on the effect of telavancin in comparison with linezolid on endotracheal tube biofilm in the IAMR pig model with methicillin-resistant Staphylococcus aureus pneumonia. This study is coordinated by Dr. Laia Fernàndez-Barat and Prof. Antoni Torres, as its Principal Investigator, and isbased on previous studies by the research group in the porcine animal model.
Kasra also works in the microbiological analysis of respiratory samples from various projects of the animal model.
-
Friday, 07/12/2019
Prof. Antoni Torres considered Top Expertise in Respiratory Tract Infections Worldwide
Information available online and based on 98,806 articles published since 2008
Prof. Antoni Torres, the IAMR group leader, is very high ranked on the source:
http://www.expertscape.com/ex/respiratory+tract+infections in which a ranking for country, city or institution are also available based on 98,806 scientific and clinical articles published since 2008.
-
Monday, 06/17/2019
First scientific Workshop for patients with bronchiectasis
The workshop was sponsorized by SEPAR pacientes, GlaxoSmithKline (GSK), Mundipharma and Chiesi and it was organized by the Dr. Torres bronchiectasis group at Hospital Clínic
Ninety five patients attended the last 31st of May the first scientific Workshops addressed to patients who suffered from bronchiectasis. The Workshops program included the inaugural welcome message from Dr. Antoni Torres, the head of the respiratory ICU and bronchiectasis monographic consultation at the Hospital Clinic and Dr. Joan Albert Barberà, Head of Pneumology Service of the Hospital Clinic. Dr. Carmen Hernández, as responsible for “dispositivo transversal de hospitalización a domicilio” also participated during the opening. Then, the program included three scientific presentations by Dr. Rosanel Amaro, coordinator of the bronchiectasis monographic consultation at the Hospital Clinic, Victoria Alcaraz, specialist in respiratory physiotherapy focused in bronchiectasis, Dr. Laia Fernández-Barat, coordinator of the research microbiology laboratory, Marta Almagro, a very involved patient diagnosed from bronchiectasis when she was a child and María Rodríguez, representative of the association of patients with hypertension.
-
Monday, 06/17/2019
The IAMR research team has been successful in the 2018 call for the Spanish Society of Pneumology and Thoracic Surgery (SEPAR)
The SEPAR 2018 Grants of Fundació Respira (Spanish Lung Foundation) will invest around 600.000 euros in research
Antoni Torres, Miquel Ferrer, Enric Barbeta, Laia Fernández and Catia Cilloniz and obtained funding from the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) - Fundació Respira grants (http://www.separ.es) to carry out their research projects in the field of respiratory diseases.
Prof. Dr. Antoni Torres obtained a SEPAR 2018 grant for his project: Cardiac injury due to severe pneumococcal pneumonia: an evaluation of the effects of corticosteroids and macrolides.
Dr. Miquel Ferrer and Enric Barbeta obtained a SEPAR 2018 grant for his project: Mechanical Power, Driving Pressure and Biotrauma in the acute respiratory distress syndrome.
Dr. Laia Fernández-Barat obtained a SEPAR 2018 grant for his project: The importance of Pseudomonas aeruginosa biofilms in the exacerbations of patients with bronchiectasis with or without chronic obstructive pulmonary diseases.
Dr. Catia Cilloniz obtained a SEPAR 2018 grant for his project: Characterization of the acquired immune response in patients with community acquired pneumonia.
SEPAR-Fundació Respira awards a number of grants each year with the aim of encouraging research in the field of respiratory disease.
-
Tuesday, 05/14/2019
Dr. Catia Cillóniz receives the distinction of "Fellow of ERS (FERS) 2019" from the European Respiratory Society
This distinction recognizes excellence in research, education and clinical leadership in the area of respiratory medicine
Dr. Cilloniz is a researcher at the Pneumology Service of Hospital Clinic de Barcelona, researcher CIBERES, member of the SEPAR, associate professor at the University of Barcelona and coordinator of the research line on Community- Acquired Pneumonia.
The new "Fellows of ERS (FERS)" are selected each year based on their publication history and their outstanding contributions to the field of respiratory medicine. In addition to the prestige that the title confers, the FERS form an advisory board of the Society to intervene on relevant issues of respiratory medicine.
-
Thursday, 04/04/2019
The bronchiectasis research line awarded by the Catalan Society of Pneumology
The award was for the oral comunication on Pseudomonas aeruginosa and viscoelastic proprierties of mucus
Victoria Alcaraz, member of our research team, received the first price to the best oral communication on the area of fisiotherapy and respiratory nursing in the XXXVII pneumological day of Catalan Society of Pneumology (SOCAP) for her investigations in the alterations of the viscoelasticity properties of the mucus by the presence of mucoid Pseudomonas aeruginosa in bronchiectasis patients.
-
Monday, 03/25/2019
Gianluigi Li Bassi selected by the BITRECS program in Prof. Antoni Torres research group
This competitive program selects excellent clinicians-scientist for translational research environment of IDIBAPS
The second call for the program 'Biomedicine international training research program for excellent clinician-scientists' (BITRECS) has been resolved.
Dr. Gianluigi Li Bassi: From Italy, he lives in Australia. He joins the research group Applied Research in Respiratory Diseases, directed by Prof. Antoni Torres, in the outgoing format: part of the project will be carried out at IDIBAPS and part in Australia, with a brief stay in Brazil.
